MOG-IgA as a Potential Marker of Germinal Center Activity.
Journal article
Handel AE. et al, (2024), JAMA Neurol, 81
The effect of smoking on MRI lesion resolution in NMOSD-AQP4 and MOGAD.
Journal article
Berhanu D. et al, (2023), Mult Scler
Do Early Relapses Predict the Risk of Long-Term Relapsing Disease in an Adult and Paediatric Cohort with MOGAD?
Journal article
Chen B. et al, (2023), Ann Neurol
A systematic literature review to examine the considerations around pregnancy in women of child-bearing age with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) or aquaporin 4 neuromyelitis optica spectrum disorder (AQP4+ NMOSD).
Journal article
Leite MI. et al, (2023), Mult Scler Relat Disord, 75
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
Journal article
Howard JF. et al, (2023), The Lancet Neurology, 22, 395 - 406
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Conference paper
Oertel FC. et al, (2023), J Neurol Neurosurg Psychiatry
Reply to the Letter to the Editor in response to "Autoantibody levels as biomarkers of disease activity in management of myasthenia gravis: A systematic review and expert appraisal".
Journal article
Meisel A. et al, (2023), Eur J Neurol
Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease.
Journal article
Camera V. et al, (2023), Brain Commun, 5
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.
Journal article
Asseyer S. et al, (2023), Front Neurol, 14
Anterior optic pathway pathology in CNS demyelinating diseases
Conference paper
Pisa M. et al, (2022), Brain, 145, 4308 - 4319
The role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: a systematic review and expert appraisal.
Journal article
Meisel A. et al, (2022), Eur J Neurol
Longitudinal Retinal Changes in MOGAD
Journal article
Oertel FC. et al, (2022), Annals of Neurology, 92, 476 - 485
Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis.
Journal article
Al-Diwani A. et al, (2022), Brain, 145, 2742 - 2754
Rituximab abrogates aquaporin-4–specific germinal center activity in patients with neuromyelitis optica spectrum disorders
Journal article
Damato V. et al, (2022), Proceedings of the National Academy of Sciences, 119
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
Journal article
Chen JJ. et al, (2022), JAMA Neurol
Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders
Journal article
Lu A. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, 188 - 195
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United Kingdom.
Journal article
Satukijchai C. et al, (2022), JAMA Netw Open, 5
Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
Journal article
Camera V. et al, (2021), JAMA Netw Open, 4
Comorbidities in older patients with myasthenia gravis - Comparison between early- and late-onset disease.
Journal article
Klimiec-Moskal E. et al, (2021), Acta Neurol Scand
Retinal Optical Coherence Tomography in Neuromyelitis Optica
Journal article
Oertel FC. et al, (2021), Neurology - Neuroimmunology Neuroinflammation, 8, e1068 - e1068